Cargando…
Iron deposition in Parkinson’s disease by quantitative susceptibility mapping
BACKGROUND: Patients with Parkinson’s disease (PD) have elevated levels of brain iron, especially in the nigrostriatal dopaminergic system. The purpose of this study was to evaluate the iron deposition in the substantia nigra (SN) and other deep gray matter nuclei of PD patients using quantitative s...
Autores principales: | Chen, Qiqi, Chen, Yiting, Zhang, Yue, Wang, Furu, Yu, Hongchang, Zhang, Caiyuan, Jiang, Zhen, Luo, Weifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532252/ https://www.ncbi.nlm.nih.gov/pubmed/31117957 http://dx.doi.org/10.1186/s12868-019-0505-9 |
Ejemplares similares
-
Genetic impacts on nigral iron deposition in Parkinson's disease: A preliminary quantitative susceptibility mapping study
por: Wu, Jingjing, et al.
Publicado: (2023) -
Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping
por: Fu, Xiaodi, et al.
Publicado: (2021) -
Quantitative Susceptibility Mapping of Brain Iron Deposition in Patients With Recurrent Depression
por: Duan, Xinxiu, et al.
Publicado: (2022) -
Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping
por: Shahmaei, Vahid, et al.
Publicado: (2019) -
Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus
por: Li, Wanyao, et al.
Publicado: (2022)